Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Blood (2023) 141 (16): 1971–1981.

https://doi.org/10.1182/blood.2022017734

Published: 2023

Includes: Supplemental data

Journal Articles

Safety and Effectiveness of Ruxolitinib in Real-World Patients with Myelofibrosis: A 2-Year Observational Study from Taiwan

Ming-Chung Kuo, Chien-Chin Lin, Hsuan-Yu Lin, Jyh-Pyng Gau, Ming-Chung Wang, Ming-Chih Chang, Tsung-Chih Chen, Shih-Peng Yeh, Yeu-Chin Chen, Sr., Cih-En Huang, I-Ju Chiang, Chu-Han Chung, Yee-Ming Lee, Fan-Chen Ku, Cheng-Shyong Chang

Blood (2022) 140 (Supplement 1): 9709–9710.

https://doi.org/10.1182/blood-2022-156146

Published: 2022

Journal Articles

The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Blood (2021) 138 (Supplement 2): LBA-1.

https://doi.org/10.1182/blood-2021-154729

Published: 2021

Journal Articles

NOVEL-1 st : A Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Hwang Wen-Li, MD, Tsung-Chih Chen, MD, Shyuann-Yuh Lin, MD, Ming-Chih Chang, MD, Pei-Ching Hsiao, MD, Li-Yuan Bai, PhD, Ching-Yuan Kuo, Yeu-Chin Chen, MD, Ta-Chih Liu, MD PhD, Jyh-Pyng Gau, MD, Po-Nan Wang, MD, Chieh-Wen Chen, Yee-Ming Lee, PhD, Fan-Chen Ku, MD, Jih-Luh Tang, MD, PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137327

Published: 2020

Journal Articles

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

Hsin-An Hou, Chien-Chin Lin, MD, Ming-Chung Kuo, MD, Shyuann-Yuh Lin, MD, Jyh-Pyng Gau, MD, Ming-Chung Wang, MD, Ming-Chih Chang, MD, Tsung-Chih Chen, MD, Su-Peng Yeh, MD, Yeu-Chin Chen, MD, Cih-En Huang, MD, Chieh-Wen Chen, MD, Yee-Ming Lee, PhD, Fan-Chen Ku, MD, Lee-Yung Shih, MD

Blood (2019) 134 (Supplement_1): 5374.

https://doi.org/10.1182/blood-2019-129645

Published: 2019

Journal Articles

An External Validation Study for Current Risk Scoring Models in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Chia-Jen Liu, MD, Hong Ying-Chung, MD, Chiu-Mei Yeh, MS, Chun-Kuang Tsai, MD, Liang-Tsai Hsiao, MD PhD, Hao-Yuan Wang, MD, Yao-Chung LIU, MD, Jyh-Pyng Gau, MD, Po-Shen Ko, MD, Jin-Hwang Liu, MD PhD, Po-Min Chen, MD

Blood (2019) 134 (Supplement_1): 3861.

https://doi.org/10.1182/blood-2019-129597

Published: 2019

Journal Articles

The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients

Wen-Chun Chen, MD, Jyh-Pyng Gau, Sr., MD, Liang-Tsai Hsiao, MD PhD, Chia-Jen Liu, MD, Yao-Chung LIU, MD, Hao-Yuan Wang, MD, Po-Shen Ko, MD, Jin-Hwang Liu, MD PhD, Tzeon-Jye Chiou, MD

Blood (2019) 134 (Supplement_1): 4608.

https://doi.org/10.1182/blood-2019-125179

Published: 2019

Journal Articles

NOVEL-1 st : Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Hwang Wen-Li, MD, Shao-Min Han, MD, Shyuann-Yuh Lin, MD, Ming-Chih Chang, MD, Li-Yuan Bai, PhD, Pei-Ching Hsiao, MD, Ching-Yuan Kuo, Yeu-Chin Chen, MD, Ta-Chih Liu, MD PhD, Po-Nan Wang, MD, Jyh-Pyng Gau, MD, Yee-Ming Lee, PhD, Fan-Chen Ku, Jih-Luh Tang, MD

Blood (2018) 132 (Supplement 1): 3019.

https://doi.org/10.1182/blood-2018-99-112342

Published: 2018

Journal Articles

Peripheral Stem Cell Transplantation Versus Bone Marrow Transplantation in Severe Aplastic Anemia - a Cohort of 149 Patients from a Single Medical Center in Taiwan

Po-Shen Ko, MD, Yao-Chung LIU, MD, Chiu-Mei Yeh, MS, Hao-Yuan Wang, MD, Ying-Chung Hong, MD, Jyh-Pyng Gau, MD, Liang-Tsai Hsiao, MD PhD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Po-Min Chen, MD, Kuo-Wei Chen, MD, Jin-Hwang Liu, MD PhD, Chia-Jen Liu, PhD

Blood (2017) 130 (Supplement 1): 1189.

https://doi.org/10.1182/blood.V130.Suppl_1.1189.1189

Published: 2017

Journal Articles

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

Yao-Chung LIU, MD, Ting-An Lin, MD, Po-Shen Ko, MD, Hao-Yuan Wang, MD, Sheng-Hsuan Chien, MD, Chia-Jen Liu, MD PhD, Tzeon-Jye Chiou, MD, Liang-Tsai Hsiao, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2017) 130 (Supplement 1): 4527.

https://doi.org/10.1182/blood.V130.Suppl_1.4527.4527

Published: 2017

Journal Articles

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Chia-Jen Liu, MD PhD, Chia-Hsin Lin, MD, Ying-Chung Hong, MD, Ching-Fen Yang, MD, Huai-Che Yang, MD, Li-Yu Fay, MD, Chiu-Mei Yeh, MS, Jyh-Pyng Gau, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Jin-Hwang Liu, MD PhD, Yao-Chung Liu, MD, Chung-Jen Teng, MD

Blood (2017) 130 (Supplement 1): 2858.

https://doi.org/10.1182/blood.V130.Suppl_1.2858.2858

Published: 2017

Journal Articles

The European Group for Blood and Marrow Transplantation Risk Score Predicts Outcome of Elderly Patients with Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome

Sheng-Hsuan Chien, MD, Yao-Chung LIU, MD, Chia-Jen Liu, PhD, Jin-Hwang Liu, MD PhD, Jyh-Pyng Gau, MD, Tzeon-Jye Chiou, MD

Blood (2017) 130 (Supplement 1): 2041.

https://doi.org/10.1182/blood.V130.Suppl_1.2041.2041

Published: 2017

Journal Articles

Spontaneous Post-Transplant Air-Leak Syndrome in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Sheng-Hsuan Chien, MD, Yao-Chung Liu, MD, Nai-Wen Fan, MD, Chia-Jen Liu, PhD, Tzeon-Jye Chiou, MD, Cheng-Hwai Tzeng, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2016) 128 (22): 5780.

https://doi.org/10.1182/blood.V128.22.5780.5780

Published: 2016

Journal Articles

Invasive Mold Infections in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Sheng-Hsuan Chien, MD, Yao-Chung Liu, MD, Nai-Wen Fan, MD, Chia-Jen Liu, PhD, Tzeon-Jye Chiou, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2016) 128 (22): 3434.

https://doi.org/10.1182/blood.V128.22.3434.3434

Published: 2016

Journal Articles

Acute Myeloid Leukemia with Erythroid Predominance: A Reassessment Using Criteria Revised in the 2016 World Health Organization Classification

Po-Shen Ko, Yao-Chung Liu, Chiu-Mei Yeh, Liang-Tsai Hsiao, MD, Cheng-Hwai Tzeng, MD, Jyh-Pyng Gau, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Chia-Jen Liu, PhD, Po-Min Chen, MD PhD, Jin-Hwang Liu, MD PhD

Blood (2016) 128 (22): 4014.

https://doi.org/10.1182/blood.V128.22.4014.4014

Published: 2016

Journal Articles

Mycobacterial Infections in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study in a High Endemic Area

Liu Yao-Chung, Chi-Jung Wu, Sheng-Hsuan Chien, MD, Nai-Wen Fan, MD, Ming-Hung Hu, MD, Jyh-Pyng Gau, MD, Chia-Jen Liu, PhD, Yuan-Bin Yu, MD, Liang-Tsai Hsiao, MD, Tzeon-Jye Chiou, MD, Jin-Hwang Liu, MD PhD

Blood (2016) 128 (22): 2202.

https://doi.org/10.1182/blood.V128.22.2202.2202

Published: 2016

Journal Articles

Aberrant Let7a/HMGA2 Signaling Axis with Unique Clinical Phenotype in JAK2 -Mutated Myeloproliferative Neoplasms

Chia-Chen Hsu, PhD, Chih-Cheng Chen, MD PhD, Jyh-Pyng Gau, MD PhD, Cih-En Huang, MD, Jie-Yu You, MD PhD, Jrhau Lung, PhD, YI-Yang Chen, Hsing-Ying Ho, MS, Chian-Pei Li, MS, Chang-Hsien Lu, MD, Kuan-Der Lee, MD PhD

Blood (2016) 128 (22): 5492.

https://doi.org/10.1182/blood.V128.22.5492.5492

Published: 2016

Journal Articles

Decision-Tree Algorithm Optimize Hematopoietic Progenitor Cell-Based Prediction in Peripheral Blood Stem Cell Mobilization

Chia-Yun Wu, Tzeon-Jye Chiou, MD, Chun-Yu Liu, Feng-Chang Lin, Jeong-Shi Lin, Man-Hsin Hung, Liang-Tsai Hsiao, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD, Hsiu-Ju Yen, Giun-Yi Hung, MD, Hui-Chi Hsu, Cheng-Hwai Tzeng, Muh-Hwa Yang, Po-Min Chen, Yuan-Bin Yu

Blood (2015) 126 (23): 1903.

https://doi.org/10.1182/blood.V126.23.1903.1903

Published: 2015

Journal Articles

Histone Deacetylation Inhibitor Sensitizes T-ALLs to Topoisomerase II Inhibitor By Attenuating G2 Cell Cycle Arrest and Blocking Nuclear Entry of Ctip during DNA Repair

Jin-Hwang Liu, MD PhD, Yu-Hern Lin, MS, Hon-Wen Liu, PhD, Jyh-Pyng Gau, MD

Blood (2015) 126 (23): 4862.

https://doi.org/10.1182/blood.V126.23.4862.4862

Published: 2015

Journal Articles

Risk of Early Mortality in Patients with Newly Diagnosed Multiple Myeloma

Chia-Jen Liu, MD, Pei Hsu, MD, Ting-Wei Lin, MD, Jyh-Pyng Gau, MD, Liang-Tsai Hsiao, MD, Cheng-Hwai Tzeng, MD, Po-Min Chen, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Yao-Chung Liu, MD, Jing-Hwang Liu, MD

Blood (2015) 126 (23): 5306.

https://doi.org/10.1182/blood.V126.23.5306.5306

Published: 2015

NARROW

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Safety and Effectiveness of Ruxolitinib in Real-World Patients with Myelofibrosis: A 2-Year Observational Study from Taiwan

The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

NOVEL-1 st : A Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

An External Validation Study for Current Risk Scoring Models in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients

NOVEL-1 st : Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Peripheral Stem Cell Transplantation Versus Bone Marrow Transplantation in Severe Aplastic Anemia - a Cohort of 149 Patients from a Single Medical Center in Taiwan

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

The European Group for Blood and Marrow Transplantation Risk Score Predicts Outcome of Elderly Patients with Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome

Spontaneous Post-Transplant Air-Leak Syndrome in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Invasive Mold Infections in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia with Erythroid Predominance: A Reassessment Using Criteria Revised in the 2016 World Health Organization Classification

Mycobacterial Infections in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study in a High Endemic Area

Aberrant Let7a/HMGA2 Signaling Axis with Unique Clinical Phenotype in JAK2 -Mutated Myeloproliferative Neoplasms

Decision-Tree Algorithm Optimize Hematopoietic Progenitor Cell-Based Prediction in Peripheral Blood Stem Cell Mobilization

Histone Deacetylation Inhibitor Sensitizes T-ALLs to Topoisomerase II Inhibitor By Attenuating G2 Cell Cycle Arrest and Blocking Nuclear Entry of Ctip during DNA Repair

Risk of Early Mortality in Patients with Newly Diagnosed Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only